Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Frattamaggiore

20 clinical trials in Frattamaggiore, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Frattamaggiore at a glance
20
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

20 trials in Frattamaggiore

Open in trial search

Alcoholism

Recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Oxybate
  • Sponsor:Laboratorio Farmaceutico C.T. S.r.l.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Janssen - Cilag International
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Tyra-300-B01
  • Sponsor:Tyra Biosciences Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Daiichi Sankyo Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Panitumumab
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Azienda USL IRCCS Di Reggio Emilia
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Panitumumab
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Palbociclib
  • Sponsor:Consorzio Oncotech
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Fondazione Radioterapia Oncologica Onlus
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:University Of Nottingham

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Frattamaggiore

What the registry says about research in the country

01 Oncology - Breast Cancer

Studies focusing on hormone receptor-positive breast cancer treatments, evaluating novel therapeutic approaches for patients with advanced disease. Research includes assessment of targeted therapies and hormone-based treatments.

  • Advanced treatment strategies for HER2-negative breast cancer
  • Hormone therapy resistance management
  • CDK4/6 inhibitor combinations
02 Oncology - Colorectal Cancer

Investigation of treatments for metastatic colorectal cancer, particularly focusing on patients with specific genetic profiles. Studies evaluate combination therapies and treatment scheduling approaches.

  • RAS/BRAF wild-type targeted therapies
  • First-line treatment optimization
  • Immunotherapy combinations
03 Oncology - Urological Cancers

Research on urothelial carcinoma and prostate cancer, exploring innovative treatment combinations and targeted therapies. Studies assess both early-stage and advanced disease management.

  • Advanced prostate cancer treatments
  • Bladder cancer therapy
  • Combination immunotherapy approaches
04 Neurological Conditions

Clinical research addressing acute cerebral hemorrhage management, with focus on improving patient outcomes through early intervention strategies.

  • Stroke treatment
  • Emergency medicine protocols
  • Hemorrhage management
05 Addiction Medicine

Studies evaluating treatments for alcohol dependence, focusing on reducing consumption and maintaining abstinence in high-risk populations.

  • Alcohol consumption reduction
  • Treatment of addiction
  • Risk level management
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.